PCA
MRTX

Providence Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Providence Capital Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11
Closed -$1K – 474
2022
Q1 		$1K Buy
+11
New +$1K ﹤0.01% 448